GlobeStar Therapeutics Corporation
GSTC
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.97% | -6.84% | 53.28% | 72.66% | -753.86% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -47.14% | 32.08% | -44.79% | 17.07% | 32.26% |
| Total Other Non-Cash Items | -156.36% | -5.60% | -76.96% | -90.30% | 6,187.08% |
| Change in Net Operating Assets | 41.52% | 45.53% | -43.24% | 38.96% | 58.84% |
| Cash from Operations | -64.52% | 71.03% | 41.13% | -80.85% | 25.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 551.28% | -84.58% | -37.84% | 126.11% | 8,900.00% |
| Total Debt Repaid | 44.44% | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -100.00% | 0.00% | -45.31% | 16.36% | 243.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 64.52% | -71.03% | -41.13% | 81.75% | -13.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 100.00% | 97.33% |